According to a latest study by Transparency Market Research (TMR), the global interventional cardiology devices market will firmly remain on the growth track thanks to the rising incidence of coronary artery disease, but the impact of this growth will be softened to some degree by a decrease in the average selling price of stents, a key product in the market. The report, published under the title, “Interventional Cardiology Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2022," by Transparency Market Research, finds that the market’s valuation was US$8.7 bn in 2013, and will rise to US$11.2 bn by 2022, at a 2.9% CAGR through the forecast period.






Read More: http://www.transparencymarketresearch.com/interventional-cardiology-devices.html

Coronary artery bypass surgery (CABG) was invented 50 years ago for the treatment of complex ischemia and multi-vessel coronary artery disease (CAD). However, CABG procedures (according to the studies conducted by the NCBI) is witnessing decline due to evolution of interventional techniques. Interventional cardiology is a minimally invasive catheter based technology that enables treatment of coronary artery disease. Minimally invasive surgeries have advantages such as shorter hospital stay, reduced cost, minimal incision, less post-surgical complications and shorter recovery time. Geriatric population and rising prevalence of coronary artery diseases are the prime reasons driving the growth of global interventional cardiology. Rising prevalence of lifestyle habits such as smoking, rising incidence of obesity, and dietary irregularities are responsible for the growth of cardiac artery disease prevalence in the world. In Europe, CAD accounts for 1.9 million deaths each year. Moreover, 1 individual in 5 (21% men, 22% women) dies from coronary artery disease in the Europe. The disorder is also one of the most common causes of premature deaths (aged